Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2017

01-10-2017 | Editorial

Irrational Exuberance in Medicine

Author: Richard L. Kravitz, MD, MSPH

Published in: Journal of General Internal Medicine | Issue 10/2017

Login to get access

Excerpt

In 1996, former Federal Reserve Board chair Alan Greenspan warned that “irrational exuberance” may have inflated stock asset values to unsustainable heights. Greenspan was concerned with economics, not health care, but he would surely see the parallels with some recent medical enthusiasms. The rise in prescription opioid use is one example. According to the Centers for Disease Control (CDC), on an average day in 2014, more than 650,000 opioid prescriptions were dispensed, 3900 people initiated nonmedical use of prescription opioids, and 78 people died from an opioid-related overdose (https://​www.​hhs.​gov/​sites/​default/​files/​Factsheet-opioids-061516.​pdf). Though 2015 data show a decline in total opioid prescriptions for the first time in years, the problem continues to command widespread attention. …
Literature
2.
go back to reference Kim H, Hartung DM, Jacob RL, McCarty D, McConnell KJ. The concentration of opioid prescriptions by providers and among patients in the Oregon Medicaid Program. Psychiatr Serv. 2016;67(4):397-404.CrossRefPubMedPubMedCentral Kim H, Hartung DM, Jacob RL, McCarty D, McConnell KJ. The concentration of opioid prescriptions by providers and among patients in the Oregon Medicaid Program. Psychiatr Serv. 2016;67(4):397-404.CrossRefPubMedPubMedCentral
3.
go back to reference Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CWC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CWC, Day RO, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225.
4.
go back to reference Nugent SM, Dobscha SK, Morasco BJ, et al. Substance use disorder treatment following clinician-initiated discontinuation of long-term opioid therapy resulting from an aberrant urine drug test. J Gen Intern Med. doi:10.1007/s11606-017-4084-0 Nugent SM, Dobscha SK, Morasco BJ, et al. Substance use disorder treatment following clinician-initiated discontinuation of long-term opioid therapy resulting from an aberrant urine drug test. J Gen Intern Med. doi:10.​1007/​s11606-017-4084-0
5.
go back to reference White VanGompel EC, Franks P, Robbins JA, et al. Incidence and predictors of repeat bone mineral densitometry: a longitudinal cohort study. J Gen Intern Med. doi:10.1007/s11606-017-4094-y White VanGompel EC, Franks P, Robbins JA, et al. Incidence and predictors of repeat bone mineral densitometry: a longitudinal cohort study. J Gen Intern Med. doi:10.​1007/​s11606-017-4094-y
Metadata
Title
Irrational Exuberance in Medicine
Author
Richard L. Kravitz, MD, MSPH
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 10/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4142-7

Other articles of this Issue 10/2017

Journal of General Internal Medicine 10/2017 Go to the issue

Letter to the Editor

Who Gets Testosterone?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.